Objective: In 1940 Kasabach and Merritt described an infant with a vas
cular anomaly, extensive purpura, and thrombocytopenia; they called hi
s lesion ''capillary hemangioma.'' Hemangioma is a benign tumor that g
rows in infancy and is characterized by proliferation of endothelial c
ells and regression during childhood, Although Kasabach-Merritt syndro
me (KMS) is frequently mentioned as a possible complication of hemangi
oma, our experience suggests that the anatomic vascular lesion underly
ing the thrombocytopenia is not a ''true,'' classic, involuting type o
f hemangioma of infancy and childhood. Study design: We reviewed the c
linical and hemostasis data and the response to treatment in 22 cases
of KMS, and we analyzed the biopsy specimens of 15 of them, Results: C
linically none of the 22 patients had classic hemangioma. There was no
female preponderance. All patients had severe thrombocytopenia (lowes
t platelet count = 3000/mm(3)) and consumption of fibrinogen. Histolog
ically, none had the typical ''capillary,'' involuting type of hemangi
oma of infancy: they exhibited either a tufted angioma or a kaposiform
hemangioendothelioma pattern; all specimens also contained numerous a
bnormal lymphatic-like vessels; lymphatic malformation was the major c
omponent in two patients, The infants exhibited a heterogeneous respon
se to a number of therapeutic regimens, as noted in other reports. Sev
ere morbidity was present; three of our patients died, and one had leg
amputation. ''Residua'' were, in fact, residual vascular neoplasia, v
ariable in duration, and not a stable fibrofatty residuum, as in class
ic involuted hemangioma; only the hematologic phenomenon was ''cured''
after a period of years, Conclusions: KMS is a distinctive disease of
infancy, but the underlying vascular lesion is not a ''true,'' classi
c, involuting type of hemangioma of infancy, This is a different vascu
lar tumor with a resemblance pathologically to either tufted angioma o
r kaposiform hemangioendothelioma in association with lymphatic-like v
essels, Whether the underlying lesion in KMS is a single anatomic enti
ty or heterogeneous cannot be definitely concluded from this study, We
need a better understanding of the pathogenesis of KMS to improve our
therapeutic management.